Skip to main content
AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc. — Investor Relations & Filings

Ticker · ANTX ISIN · US0373261058 US Manufacturing
Open in API
Filings indexed 340 across all filing types
Latest filing 2022-03-21 Regulatory Filings
Country US United States of America
Listing US ANTX

About AN2 Therapeutics, Inc.

https://www.an2therapeutics.com/

AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing treatments for rare, chronic, and serious infectious diseases with high unmet medical needs. The company utilizes its proprietary boron chemistry platform to create novel small molecule therapeutics. Its development pipeline includes boron-based compounds, such as its lead candidate epetraborole, which are being investigated as potential first-in-class or best-in-class therapies. The company's mission is to deliver high-impact drugs to improve global health outcomes, with potential applications extending to oncology.

Recent filings

Filing Released Lang Actions
S-1/A
Regulatory Filings Classification · 100% confidence The document is a Form S-1/A Registration Statement Amendment No. 1 filed with the SEC for AN2 Therapeutics, Inc. It is a detailed registration statement for an initial public offering (IPO) of common stock. The text includes the SEC header, registration number, company details, offering details, risk factors, management discussion, financial statements index, and other IPO-related disclosures. This type of filing is a registration statement under the Securities Act of 1933, not an annual report, earnings release, or any other report type listed. The S-1/A is a regulatory filing used to register securities for public sale and is not covered by the provided categories except under the fallback category for miscellaneous regulatory filings. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a certification but a full regulatory filing.
2022-03-21 English
Regulatory Filings 2022
Regulatory Filings
2022-03-11 English
REGISTRATION STATEMENT ON FORM S-1
Capital/Financing Update Classification · 100% confidence The document is a Registration Statement on Form S-1 filed with the SEC, which is used for initial public offerings (IPOs) to register securities for sale to the public. It includes detailed information about the company, its business, management, financials, risk factors, and the offering itself. This type of filing is distinct from annual or quarterly reports, earnings releases, or other regulatory filings. The presence of the Form S-1 header, references to the Securities Act of 1933, and the detailed prospectus content confirm this classification. According to the provided filing definitions, this document fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities, including IPO registration statements.
2022-03-04 English
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a letter from the company's legal counsel responding to comments from the SEC staff regarding a Draft Registration Statement on Form S-1. It references amendments to the Draft Registration Statement and addresses specific SEC comments on disclosures and financial assumptions. The document is not the registration statement itself but a response letter to the SEC's comment letter. It is a regulatory communication related to the registration process, not a financial report, earnings release, or other specific filing type. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other categories.
2022-01-19 English
Capital/Financing Update 2022
Capital/Financing Update Classification · 100% confidence The document is a confidentially submitted draft registration statement on Form S-1 to the SEC, dated January 19, 2022, for AN2 Therapeutics, Inc. It is a registration statement under the Securities Act of 1933 for an initial public offering (IPO) of common stock. The text includes detailed information typical of an S-1 filing such as company overview, risk factors, use of proceeds, management discussion, executive compensation, and financial statements. This type of document is a registration statement for securities offering, which falls under the category of Capital/Financing Update (CAP) because it relates to fundraising and capital raising activities. It is not an annual report, earnings release, or any other report type. Therefore, the correct classification is CAP.
2022-01-19 English
Regulatory Filings 2021
Regulatory Filings
2021-12-03 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.